Volume | 48,047 |
|
|||||
News | (1) | ||||||
Day High | 1.0195 | Low High |
|||||
Day Low | 0.96 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Quince Therapeutics Inc | QNCX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.00 | 0.96 | 1.0195 | 0.965 | 1.00 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
291 | 48,047 | US$ 0.9773218 | US$ 46,957 | - | 0.5401 - 1.93 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:56:04 | formt | 100 | US$ 0.96 | USD |
Quince Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
83.59M | 42.87M | - | 0 | -51.66M | -1.21 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Quince Therapeutics News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QNCX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.91 | 1.0362 | 0.91 | 0.9804297 | 111,234 | 0.05 | 5.49% |
1 Month | 0.9425 | 1.0362 | 0.84 | 0.9299953 | 90,664 | 0.0175 | 1.86% |
3 Months | 1.25 | 1.31 | 0.84 | 1.05 | 94,125 | -0.29 | -23.2% |
6 Months | 1.51 | 1.70 | 0.84 | 1.21 | 189,730 | -0.55 | -36.42% |
1 Year | 0.66 | 1.93 | 0.5401 | 1.22 | 713,098 | 0.30 | 45.45% |
3 Years | 40.11 | 121.98 | 0.5401 | 12.57 | 644,565 | -39.15 | -97.61% |
5 Years | 20.00 | 121.98 | 0.5401 | 15.48 | 462,930 | -19.04 | -95.2% |
Quince Therapeutics Description
Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States. |